• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FlowMetric forms new affiliate FlowMetric Diagnostics

FlowMetric forms new affiliate FlowMetric Diagnostics

September 23, 2014
CenterWatch Staff

FlowMetric, a Doyleston, Pa.-based provider of flow cytometry and cell sorting services, has formed a new affiliate company, FlowMetric Diagnostics, for developing advanced companion diagnostics from its flow cytometry platform for use in the global health market.

Flow cytometry currently has broad applications in R&D as well as drug design. The sensitivity and analytical capabilities of the modern flow cytometry systems combined with FlowMetric Diagnostics proprietary methods could play a central role in its development of novel and innovative diagnostics.

"This new affiliate company," said Ren Capocasale, FlowMetric CEO, "represents the natural progression of the FlowMetric business into the clinical marketplace and recognizes the need for additional diagnostics."

FlowMetric Diagnostics leadership will include Amy Williams, president, and Julie Bick, Ph.D., chief scientific officer. Capocasale is chairman of the board.

"The development of new companion diagnostics through flow cytometry can help to advance personalized medicine and better meet the needs of physicians, healthcare workers and patients," said Williams.

FlowMetric Diagnostics plans to establish a state-of-the-art FDA-compliant clinical flow cytometry laboratory in which to perform CLIA-certified diagnostic tests from both the company's own assay portfolio, as well as those of partnering diagnostic companies.

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing